Shropshire CCG Effective Shared Care Agreements

The Effective Shared Care Agreements zip file contains the following documents:

• Amiodarone ESCA - December 2014
• Apomorphine SCA
• Azathioprine for non-rheumatology indications ESCA - December 2014
• Azathioprine Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 (co-developed with RJAH)
• Ciclosporin oral for dermatology indications ESCA - December 2014
• Ciclosporin Oral Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 (co-developed with RJAH)
• D-Penicillamine Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 (co-developed with RJAH)
• Denosumab SCA
• Dronedarone ESCA - December 2014
• Leflunomide Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 (co-developed with RJAH)
• Methotrexate for dermatological indications ESCA - December 2014
• Methotrexate Oral and Parenteral Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 (co-developed with RJAH)
• Riluzole Effective Shared Care Agreement for patients with amyotrophic lateral sclerosis - November 2013
• Sodium aurothiomalate (Gold therapy) Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 (co-developed with RJAH)
• Somatropin (recombinant Human Growth Hormone) treatment in adults
• Sulfasalazine for gastroenterological indications ESCA - December 2014
• Sulfasalazine Rheumatology Local Safety Monitoring Schedule for Shared Care - August 2015 (co-developed with RJAH)

Mental Health Effective Shared Care Agreements

• Access Effective Shared Care Agreements on South Staffordshire and Shropshire Healthcare NHS Foundation Trust (SSSFT) website.